Clinical & Translational Oncology · Nov 11, 2026

Effectiveness of screening for melanoma and keratinocyte carcinoma: a systematic review and meta-analysis

By Zhou M, Tang H, Lei L et al.

Background Skin cancer screening may facilitate earlier diagnosis, but potential benefits must be balanced against unnecessary procedures, overdiagnosis, costs, and harms. We evaluated randomized screening, high-risk surveillance, and diagnostic-triage interventions for melanoma and keratinocyte carcinoma. Methods MEDLINE, Scopus, Web of Science Core Collection, and CENTRAL were searched through July 2026. Randomized trials involving community populations, high-risk groups, or patients with suspicious lesions were eligible. Two reviewers independently selected studies and extracted data. Clinician-performed skin examination attendance was synthesized using restricted maximum-likelihood random-effects estimation with Hartung–Knapp adjustment. Clinically incompatible outcomes were summarized individually. Risk of bias and certainty were assessed using RoB 2 and GRADE. Results Fourteen publications representing 13 independent randomized trial families were included. Three trials contributed to the screening attendance analysis. The pooled odds ratio (OR) was 1.16 (95% CI 0.81–1.66; P = .215; I2 = 0.0%), indicating no significant improvement. Intensive digital surveillance did not significantly alter melanoma detection (risk ratio [RR], 0.65; 95% CI 0.38–1.10) or keratinocyte carcinoma detection (RR, 1.32; 95% CI 0.96–1.83), but increased participants undergoing excision (RR, 1.16; 95% CI 1.01–1.33). Reflectance confocal microscopy reduced index lesion excisions (RR, 0.54; 95% CI 0.51–0.56). Teledermoscopy improved diagnostic sensitivity and specificity, whereas mobile-assisted self-examination showed lower lesion-level sensitivity than naked-eye examination. Seven publications (50.0%) had high risk of bias, and 10 of 11 outcomes had very low certainty evidence. Conclusions Screening-promotion interventions did not significantly improve clinician examination attendance. Diagnostic technologies altered selected decisions and procedures, but evidence remained insufficient to establish consistent patient-relevant net clinical benefit.

doi.org/10.1007/s12094-026-04604-1PubMed 43013226Interventions

AgingResearch.News